The functional consequences of genetic variation in mammalian regulatory elements are poorly understood. We report the in vivo dissection of three mammalian liver enhancers at single nucleotide resolution via a massively parallelized reporter assay. For each enhancer, we synthesized a library of >100,000 mutant haplotypes with 2–3% divergence from wild-type. Each haplotype was linked to a unique sequence tag embedded within a transcriptional cassette. We introduced each enhancer library into mouse liver and measured the relative activities of individual haplotypes en masse by sequencing of the transcribed tags. Linear regression yielded highly reproducible estimates of the impact of every possible single nucleotide change on enhancer activity. The functional impact of most mutations was modest, with ~22% impacting activity by >1.2-fold, and only ~3% by >2-fold. These results suggest that mammalian enhancers are relatively robust to single nucleotide changes. Several, but not all positions with higher impact showed evidence for purifying selection, or co-localized with known liver-associated transcription factor binding sites, demonstrating the value of empirical high-resolution functional analysis.
Full author list & citation
Rupali P Patwardhan, Joseph B Hiatt, Daniela M Witten, Mee J Kim, Robin P Smith, Dalit May, Choli Lee, Jennifer M Andrie, Su-In Lee, Gregory M Cooper, Nadav Ahituv, Len A Pennacchio, Jay Shendure. Massively parallel functional dissection of mammalian enhancers in vivo. 2012-02-26. https://doi.org/10.1038/nbt.2136
A 620-bp human intronic ECR11 enhancer (hg19 chr2:169939082-169939701) was synthesized as a randomly doped haplotype library and cloned into a tagged luciferase reporter plasmid. The library was delivered to CD1 mouse liver by hydrodynamic tail-vein injection, and the processed table contains the published effect estimates for all 1,860 possible single-nucleotide substitutions.
A 302-bp candidate mouse LTV1 enhancer (mm9 chr7:29161443-29161744) was synthesized using one of two independent overlapping-oligonucleotide designs and cloned into a tagged luciferase reporter plasmid. The library was delivered to CD1 mouse liver by hydrodynamic tail-vein injection, and the processed table contains the published effect estimates for all 906 possible single-nucleotide substitutions in LTV1 replicate 1.
A 302-bp candidate mouse LTV1 enhancer (mm9 chr7:29161443-29161744) was synthesized using the second independent overlapping-oligonucleotide design and cloned into a tagged luciferase reporter plasmid. The library was delivered to CD1 mouse liver by hydrodynamic tail-vein injection, and the processed table contains the published effect estimates for all 906 possible single-nucleotide substitutions in LTV1 replicate 2.
A 259-bp human intronic ALDOB enhancer (hg19 chr9:104195570-104195828) was synthesized as a randomly doped haplotype library and cloned into a tagged luciferase reporter plasmid. The library was delivered to CD1 mouse liver by hydrodynamic tail-vein injection, and the processed table contains the published effect estimates for all 777 possible single-nucleotide substitutions.
Original supplemental and deposited inputs retained for this study. Download files individually or together as a ZIP; nested folders are preserved. Source reuse terms apply, and sequencing reads may be omitted.